Cargando…

The Role of the Mammalian Prion Protein in the Control of Sleep

Sleep disruption is a prevalent clinical feature in many neurodegenerative disorders, including human prion diseases where it can be the defining dysfunction, as in the case of the “eponymous” fatal familial insomnia, or an early-stage symptom as in certain types of Creutzfeldt-Jakob disease. It is...

Descripción completa

Detalles Bibliográficos
Autores principales: Roguski, Amber, Gill, Andrew C.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5750582/
https://www.ncbi.nlm.nih.gov/pubmed/29149024
http://dx.doi.org/10.3390/pathogens6040058
Descripción
Sumario:Sleep disruption is a prevalent clinical feature in many neurodegenerative disorders, including human prion diseases where it can be the defining dysfunction, as in the case of the “eponymous” fatal familial insomnia, or an early-stage symptom as in certain types of Creutzfeldt-Jakob disease. It is important to establish the role of the cellular prion protein (PrP(C)), the key molecule involved in prion pathogenesis, within the sleep-wake system in order to understand fully the mechanisms underlying its contribution to both healthy circadian rhythmicity and sleep dysfunction during disease. Although severe disruption to the circadian rhythm and melatonin release is evident during the pathogenic phases of some prion diseases, untangling whether PrP(C) plays a role in circadian rhythmicity, as suggested in mice deficient for PrP(C) expression, is challenging given the lack of basic experimental research. We provide a short review of the small amount of direct literature focused on the role of PrP(C) in melatonin and circadian rhythm regulation, as well as suggesting mechanisms by which PrP(C) might exert influence upon noradrenergic and dopaminergic signaling and melatonin synthesis. Future research in this area should focus upon isolating the points of dysfunction within the retino-pineal pathway and further investigate PrP(C) mediation of pinealocyte GPCR activity.